<p>Actor Sivakarthikeyan's latest movie <em>Doctor </em>hit the screens on Saturday much to the delight of fans. The biggie has created a fair deal of buzz among a section of the audience, which suggests that things are heading in the right direction. So, does <em>Doctor </em>have what it takes to emerge as a commercial success? Here is our SWOT analysis.</p>.<p><strong>Strength: SK in a new avatar</strong></p>.<p>Judging by the trailer, <em>Doctor </em>is an action-packed drama with an engaging narrative. It features Sivakarthikeyan in a new avatar, which is completely different from anything that he has sported in the past. Dialogues such as 'you are my soldiers' have a distinct mass feel and should appeal to the younger audience. The background score is a distinct highlight of the film and is likely to elevate the reel action. </p>.<p><strong>Weakness: Lack of bankable names</strong></p>.<p>Sivakarthikeyan is an established name but the same cannot be said about director Nelson. While the filmmaker scored a hit with his maiden movie <em>Kolamaavu Kokila</em>, he is not in the same league as star storytellers such as Mohan Raja, Shankar or A R Murugadoss. Similarly, Priyanka Arul Mohan does not have a market in Tamil Nadu as this is the first Tamil movie of her career. These factors might affect film's prospects if the content is not up to the mark. </p>.<p><strong>Opportunity: The audience is ready</strong></p>.<p>The Tamil audience is more than willing to watch movies in theatres even in Covid-19 times. This became clear when <em>Master</em>, starring Vijay, emerged as a blockbuster despite the fact that seating capacity in theatres was capped at 50 per cent. Similarly, films such as <em>Sulthan </em>and <em>Karnan </em>made a strong impact at the box office in the post-pandemic era. Given Sivakarthikeyan's popularity, <em>Doctor </em>too may exceed expectations. It should also benefit from the Ayudha Puja holidays and festivities. </p>.<p><br /><strong>Threat: Competition</strong></p>.<p>The film is likely to face competition from this week's big Hollywood release <em> A Quiet Place II,</em> especially in Chennai. <em>No Time To Die</em>, which was released in theatres on September 30, may affect its performance in mass markets given the Bond saga's cult following. </p>
<p>Actor Sivakarthikeyan's latest movie <em>Doctor </em>hit the screens on Saturday much to the delight of fans. The biggie has created a fair deal of buzz among a section of the audience, which suggests that things are heading in the right direction. So, does <em>Doctor </em>have what it takes to emerge as a commercial success? Here is our SWOT analysis.</p>.<p><strong>Strength: SK in a new avatar</strong></p>.<p>Judging by the trailer, <em>Doctor </em>is an action-packed drama with an engaging narrative. It features Sivakarthikeyan in a new avatar, which is completely different from anything that he has sported in the past. Dialogues such as 'you are my soldiers' have a distinct mass feel and should appeal to the younger audience. The background score is a distinct highlight of the film and is likely to elevate the reel action. </p>.<p><strong>Weakness: Lack of bankable names</strong></p>.<p>Sivakarthikeyan is an established name but the same cannot be said about director Nelson. While the filmmaker scored a hit with his maiden movie <em>Kolamaavu Kokila</em>, he is not in the same league as star storytellers such as Mohan Raja, Shankar or A R Murugadoss. Similarly, Priyanka Arul Mohan does not have a market in Tamil Nadu as this is the first Tamil movie of her career. These factors might affect film's prospects if the content is not up to the mark. </p>.<p><strong>Opportunity: The audience is ready</strong></p>.<p>The Tamil audience is more than willing to watch movies in theatres even in Covid-19 times. This became clear when <em>Master</em>, starring Vijay, emerged as a blockbuster despite the fact that seating capacity in theatres was capped at 50 per cent. Similarly, films such as <em>Sulthan </em>and <em>Karnan </em>made a strong impact at the box office in the post-pandemic era. Given Sivakarthikeyan's popularity, <em>Doctor </em>too may exceed expectations. It should also benefit from the Ayudha Puja holidays and festivities. </p>.<p><br /><strong>Threat: Competition</strong></p>.<p>The film is likely to face competition from this week's big Hollywood release <em> A Quiet Place II,</em> especially in Chennai. <em>No Time To Die</em>, which was released in theatres on September 30, may affect its performance in mass markets given the Bond saga's cult following. </p>